Cancer Clinical Trial
Official title:
E-MOSAIC: A Multicenter Randomized Controlled Phase III Study of Longitudinal Electronic Monitoring of Symptoms and Syndromes Associated With Advanced Cancer in Patients Receiving Anticancer Treatment in Palliative Intention
RATIONALE: A hand held electronic tool used to monitor symptoms and assess quality of life
may improve communication between patients and their doctors and improve the ability to plan
treatment for patients with advanced cancer receiving palliative care. It is not yet known
whether symptoms are better controlled with or without use of this electronic tool.
PURPOSE: This randomized phase III trial is studying an electronic tool to see how well it
records cancer symptoms in patients with advanced cancer receiving palliative care.
OBJECTIVES:
Primary
- Determine the effect of an electronic tool for monitoring symptoms and syndromes
associated with advanced cancer (E-MOSAIC) and a Longitudinal Monitoring Sheet (LoMoS)
on global quality of life (G-QOL) of patients with advanced incurable cancer receiving
palliative anticancer treatment.
Secondary
- Determine if this tool affects communication between these patients and their treating
physicians.
- Determine if this tool affects the symptoms and syndromes reported by these patients.
- Determine if this tool impacts symptom management performance.
Tertiary
- Identify factors influencing changes in G-QOL.
- Determine how patients adapt to illness and burden of treatment.
- Describe patients' decision-making preference.
OUTLINE: This is a controlled, randomized, longitudinal, multicenter study. Physicians are
stratified according to participating center. Physicians are randomized to 1 of 2 arms. All
patients allocated to a physician undergo the same intervention.
- Arm I: Patients complete a weekly symptom assessment and nutritional intake using a
Palm-based monitoring tool. Nurses record weight and Karnofsky performance status (KPS)
scores weekly. A proof of electronic transfer sheet is printed and stored.
- Arm II: Patients complete a weekly assessment comprising visual analogue scales (VAS) of
pain, fatigue, drowsiness, nausea, anxiety, depression, shortness of breath, loss of
appetite, and overall well-being; up to 3 optional symptoms selected by the patient; and
an estimated nutritional intake using an electronic tool for monitoring symptoms and
syndromes associated with advanced cancer (E-MOSAIC). Nurses record the patient's
weight, KPS score, body mass index, and assessment of current medication for pain (i.e.,
morphine-equivalent daily dose), fatigue, and anorexia/cachexia syndromes weekly. A
Longitudinal Monitoring Sheet (LoMoS) is printed (comprising VAS of pain, pain
medication, fatigue, KPS, medication for fatigue [i.e., methylphenidate hydrochloride or
epoetin alfa], anorexia, weight change, nutritional intake, medication, supplements,
counseling for anorexia, VAS of individually selected symptoms) and stored.
In both arms, patients are assessed for outcome criteria at baseline and at weeks 3 and 6
(end of study).
PROJECTED ACCRUAL: A total of 24 physicians and 192 patients will be accrued for this study.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|